ACHC

Acadia Healthcare Company, Inc. - 10-Q Summary (Q1 2026)

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2026. Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services, operating 275 facilities with approximately 12,400 beds across 40 states and Puerto Rico. The company operates through acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), and residential treatment centers.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 7.6% year-over-year, driven by a 7.3% increase in same-facility revenue. This growth was supported by a 5.6% increase in revenue per patient day and a 6.5% increase in admissions, partially offset by a 4.6% decrease in average length of stay.
• Profitability Decline: Net income attributable to the company decreased 51% to $4.1 million. This decline was primarily due to a significant increase in the effective tax rate (from 32.7% to 59.3%) driven by nondeductible executive compensation and valuation allowances, alongside higher legal settlement expenses.
• Legal and Transaction Costs: Legal settlements expense rose to $13.8 million (from $3.5 million) due to the Sandoval Litigation. Transaction, legal, and other costs decreased to $22.0 million (from $31.1 million), reflecting lower government investigation costs in the current period.
• Capital Expenditures: Cash used for capital expenditures decreased significantly to $76.6 million from $174.6 million in the prior year, with expansion capex comprising $51.5 million.

Outlook, Risks, and Management Commentary

• Legislative Impact: Management highlighted the "One Big Beautiful Bill Act" (OBBBA) passed in July 2025, which tightens Medicaid eligibility and restricts federal matching funds. While exemptions exist for the company's patient population, these changes introduce financial uncertainty and potential reimbursement reductions.
• Legal Contingencies: The company is facing ongoing DOJ and SEC investigations regarding admissions, length of stay, and billing practices. Additionally, the Sandoval Litigation settlement of $15.0 million was reached in April 2026, with $13.8 million uninsured. A sixth lawsuit related to the Desert Hills Litigation remains open with an unquantifiable liability.
• Liquidity and Debt: The company maintains a $1.0 billion revolving credit facility with $564.8 million available. The Consolidated Total Net Leverage Ratio was 3.9x at quarter-end, well within the 5.0x covenant limit. Interest expense increased to $38.3 million due to higher borrowings.
• Operational Strategy: The company continues to focus on expanding bed capacity (adding 82 beds in Q1) and navigating a tight labor market, though wage inflation remains a factor.

Investor Verification Checklist

• Legal Exposure: Verify the final status and potential financial impact of the DOJ/SEC investigations and the pending sixth Desert Hills lawsuit.
• Tax Rate Volatility: Assess the sustainability of the 59.3% effective tax rate and the specific valuation allowances recorded against state deferred tax assets.
• Medicaid Policy Risk: Monitor state-level implementation of the OBBBA provisions regarding Medicaid eligibility and provider assessments to gauge revenue impact.
• Capital Allocation: Review the $250 million remaining under the share repurchase program and the company's strategy for deploying capital amidst high interest rates.
• Working Capital: Investigate the increase in Days Sales Outstanding (DSO) to 51 days and the specific payor delays mentioned in the cash flow discussion.